SCHEMBL7091400

SCHEMBL7091400

CC(C)c1ccccc1C(=O)Oc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.59
HSD17B10 Q99714 2/20 0.59
ALOX15 P16050 1/20 0.59
MAPT P10636 4/20 0.56
KDM4E B2RXH2 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
XBP1 P17861 1/20 0.54
ALDH1A1 P00352 3/20 0.47
LMNA P02545 2/20 0.47
KMT2A Q03164 2/20 0.46
TSHR P16473 1/20 0.46
NR4A2 P43354 1/20 0.46
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
CHRM1 P11229 1/20 0.46
TBXA2R P21731 1/20 0.46
SLC6A2 P23975 1/20 0.46
PDE4A P27815 1/20 0.46
ADRA1A P35348 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27699904 0.88 HPGD (0.54) HPGDHSD17B10ALOX15MAPTKDM4E
SCHEMBL28644871 0.86 HPGD (0.53) HPGDHSD17B10ALOX15MAPTKDM4E
SCHEMBL4819311 0.86 HPGD (0.43) HPGDHSD17B10ALOX15MAPTKDM4E
SCHEMBL1788131 0.85 HPGD (0.51) HPGDHSD17B10ALOX15MAPTKDM4E
SCHEMBL28628766 0.84 MAPT (0.46) HPGDHSD17B10ALOX15MAPTKDM4E
SCHEMBL18489613 0.83 HPGD (0.51) HPGDHSD17B10KDM4EXBP1ALDH1A1
SCHEMBL29437924 0.82 HSD17B10 (0.76) HPGDHSD17B10ALOX15MAPTKDM4E
SCHEMBL69868 0.82 HSD17B10 (0.76) HPGDHSD17B10ALOX15MAPTKDM4E
Hydrogen Peroxide SCHEMBL28473316 0.81 TSHR (0.57) HPGDHSD17B10ALOX15MAPTKDM4E
SCHEMBL739463 0.80 TSHR (0.47) HPGDXBP1ALDH1A1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103351402-A Method for production of phosphate flame retardant by excess phosphorus oxychloride Tianjin lianrui flame retardant material co ltd 2013-10-16 CN disclosed
CN-103224525-A Method for producing IPPP 65 Tianjin lianrui flame retardant material co ltd 2013-07-31 CN disclosed
CN-103224524-A Method for producing IPPP 95 Tianjin lianrui flame retardant material co ltd 2013-07-31 CN disclosed
CN-103224526-A Method for producing IPPP 35 Tianjin lianrui flame retardant material co ltd 2013-07-31 CN disclosed
CN-103214518-A Method for producing IPPP (Isopropyl Phenyl diphenyl Phosphate) Tianjin lianrui flame retardant material co ltd 2013-07-24 CN disclosed
CN-103214516-A Method for producing IPPP (Isopropyl Phenyl diphenyl Phosphate) 50 Tianjin lianrui flame retardant material co ltd 2013-07-24 CN disclosed
CN-1215123-C Polyamide and polyolefine refractory composition ATOFINA (FR) 2005-08-17 CN disclosed
CN-1468906-A Polyamide and polyolefine refractory composition ���з��ɹ�˾ 2004-01-21 CN disclosed
US-20030171422-A1 New nitromethyl ketones, process for preparing them and compositions containing them MERCK PATENT GMBH (DE) 2003-09-11 US disclosed
US-6559185-B2 Nitromethyl ketone compounds having aldose reduction inhibiting properties and methods for their use MERCK PATENT GMBH (DE) 2003-05-06 US disclosed
US-20030069312-A1 Antidiabetic agents LARDY CLAUDE (FR) 2003-04-10 US disclosed
US-6043281-A ALDOSE REDUCTASE INHIBITORS; TREATMENT OR PREVENTION OF COMPLICATIONS OF DIABETES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-03-28 US disclosed
EP-0983226-A1 NEW NITROMETHYL KETONES, PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM MERCK PATENT GmbH (DE) 2000-03-08 EP disclosed
US-5932765-A REDUCTASE INHIBITORS MERCK PATENT GESELLSCHAFT MIT (DE) 1999-08-03 US disclosed
WO-1998052906-A1 NEW NITROMETHYL KETONES, PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM MERCK PATENT GMBH (DE) 1998-11-26 WO disclosed
EP-0125641-B1 ALKANOYLOXYBENZENESULFONATE SALT PRODUCTION ETHYL CORPORATION (US) 1987-03-04 EP disclosed
US-4537724-A Alkanoyloxybenzenesulfonate salt production ETHYL CORPORATION (US) 1985-08-27 US disclosed
EP-0125641-A2 Alkanoyloxybenzenesulfonate salt production ETHYL CORPORATION (US) 1984-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069312-A1 Antidiabetic agents SLC5A1, SLC5A2, GPR119 HPGD 964/4885HSD17B10 294/4885ALOX15 1007/4885
US-20030171422-A1 New nitromethyl ketones, process for preparing them and compositions containing them AKR1B1, AKR1A1, AKR1C1 HPGD 231/4885HSD17B10 183/4885ALOX15 1166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.